Form 4 for VNRX VOLITIONRX LTD
Accepted 2022-08-30 00:00:00 ET · period of report 2022-08-30 · accession 0001477932-22-006512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 | 2022-08-30 | VNRX | Reynolds Cameron John | Pres, CEO, Dir | P - Purchase | $1.61 | +3,500 | 1.20M | +0.3% | +$5,635 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-30 | P | A | 3,500 | $1.61 | 1,195,518 | D | — | — |